GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Change In Receivables

CAMP (Camp4 Therapeutics) Change In Receivables : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Change In Receivables?

Camp4 Therapeutics's change in receivables for the quarter that ended in Sep. 2024 was $0.00 Mil. It means Camp4 Therapeutics's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Camp4 Therapeutics's change in receivables for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Camp4 Therapeutics's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Camp4 Therapeutics's Accounts Receivable for the quarter that ended in Sep. 2024 was $1.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Camp4 Therapeutics's liquidation value for the three months ended in Sep. 2024 was $-177.06 Mil.


Camp4 Therapeutics Change In Receivables Historical Data

The historical data trend for Camp4 Therapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Change In Receivables Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23
Change In Receivables
- -

Camp4 Therapeutics Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial - - - - -

Camp4 Therapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camp4 Therapeutics  (NAS:CAMP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Camp4 Therapeutics's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

2. In Ben Graham's calculation of liquidation value, Camp4 Therapeutics's accounts receivable are only considered to be worth 75% of book value:

Camp4 Therapeutics's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.528-180.339+0.75 * 1+0.5 * 0
=-177.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camp4 Therapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

Camp4 Therapeutics Headlines